Description
TREN A 100 – Trenbolone Acetate 100mg/ml
TREN A 100 contains 100mg/ml of Trenbolone Acetate, widely regarded as one of the most potent anabolic agents for rapid strength gain, enhanced nutrient partitioning, and accelerated fat loss. Its short ester offers fast onset of action and better control over blood levels, making it ideal for aggressive but strategic cycles.
Trenbolone Acetate increases protein synthesis and nitrogen retention more efficiently than nearly any other compound. It significantly enhances visual muscle density and vascularity while supporting hard, dry gains without water retention. It also exhibits strong anti-catabolic effects, preserving muscle mass under intense training and caloric restriction.
Application:
Best suited for intermediate to advanced athletes aiming to maximize physique transformation in shorter cycles (6–8 weeks). Highly effective for both bulking and cutting when paired appropriately with testosterone and support compounds.
Important Note:
Trenbolone is not recommended for novice users due to its strength and potential for side effects such as insomnia, night sweats, and increased cardiovascular strain. Close monitoring and a well-planned PCT protocol are essential.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.